Chromosome 10 alterations in prostate adenocarcinoma (review)

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1329-1335

  Ittmann, Michael M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chromosome 10; Prostate adenocarcinoma; PTEN; Tumor suppressor genes

Indexed keywords

CYTOSKELETON PROTEIN; FOCAL ADHESION KINASE; INTEGRIN; PHOSPHOPROTEIN PHOSPHATASE;

CHROMOSOME 10P; CHROMOSOME 10Q; EXTRACELLULAR MATRIX; GENE REPRESSION; HETEROZYGOSITY LOSS; METASTASIS; MUTATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0031710623     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1329     Document Type: Review

References (51)

1. Visakorpi T, Kallioniemi A, Hyytinen E, Karhu R, Tammela T, Isola J and Kallioniemi O: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55: 342-347, 1995.
2. Latil A, Fournier G, Cussenot O and Lidereau R: Differential chromosome allelic imbalance in the progression of human prostate cancer. J Urol 156: 2079-2083, 1996.
3. Cunningham J, Shan A, Wick M, McDonnell S, Schaid D, Tester D, Qian J, Takahashi S, Jenkins R, Bostwick D and Thibodeau S: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56: 4475-4482, 1996.
4. Phillips S, Morton D, Lee S, Wallace D and Neoptolemus J: Loss of heterozygosity of the retinoblastoma and adenoinatous polyposis gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73: 390-395, 1994.
5. Bergerheim U, Kunimi K, Collins V and Ekman P: Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3: 215-220, 1991.
6. Latil A, Baron J, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Le Duc A, Rouesse J and Lidereau R: Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes Cancer 11: 119-125, 1994.
7. Ittmann M and Wieczorek R: Alterations of the retinoblastoma gene in clinically localized, Stage B prostate adenocarcinomas. Hum Pathol 27: 28-34, 1996.
8. Carter B, Ewing C, Ward W, Treiger B, Aalders T, Schalken J, Epstein J and Isaacs W: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87: 8751-8755, 1990.
9. Ittmann M: Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Prostate 28: 275-281, 1996.
10. Ittmann M: Allelic loss on chromosome 10 in prostate adenocarcinomas. Cancer Res 56: 2143-2147, 1996.
11. Gray I, Phillips S, Lee S, Neoptolemos J, Weissenbach J and Spurr N: Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800-4803, 1995.
12. Komiya A, Suzuki H, Ueda T, Emi M, Ito H and Shimazaki J: Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 17: 245-253, 1996.
13. Trybus T, Burgess A, Wojno K, Glover T and Macoska J: Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56: 2263-2267, 1996.
14. Feilotter H, Nagai M, Boag A, Eng C and Mulligan L: Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 16: 1743-1748, 1998.
15. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C and Lidereau R: PTEN/MMAC/TEP1 involvement in primary prostate cancers. Oncogene 16: 2879-2883, 1998.
16. Cairns P, Okami K, Halachmi N, Esteller M, Herman J, Jen J, Issacs W, Bova S and Sidransky D: Frequent inactivation on PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997-5000, 1997.
17. Suzucki H, Freije D, Nusskern D, Okami K, Cairns P, Sidransky D, Issacs W and Bova S: Interfocal heterogeneity of PTEN/MMAC1 aene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204-209, 1998.
18. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner S, Giovanella B, Ittmann M, Tycko B, Hibshoosh H, Wigler M and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 274: 1943-1947, 1997.
19. Singh B, Ittmann M and Krolewski J: Sporadic breast cancers exhibit loss of heterozygosity on chromosome 10q23 at the locus lost in Cowden disease. Genes Chromosomes Cancer 21: 166-171, 1998.
20. Steck P, Pershouse M, Jasser S, Yung A, Lin H, Ligon A, Langford L, Baumgard M, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng D and Tavtigian S: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
21. Cappellen D, Diez de Medina G, Thiery J and Radvanyi F: Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 14: 3059-3066, 1997.
22. Peiffer S, Herzog T, Tribune D, Mutch D, Gersell D and Goodfellow P: Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55: 1922-1926, 1995.
23. Nagase S, Yamakawa H, Sato S, Yajima A and Horii A: Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer. Cancer Res 57: 1630-1633, 1997.
24. Petersen I, Langreck H, Wolf G, Schwandel A, Psille R, Vogt P, Reichel M, Ried T and Dietel M: Small-cell lung cancer is characterized by a high incidence of deletions on chromosome 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75: 79-86, 1997.
25. Herbst R, Weiss J, Ehnis A, Cavanee W and Arden K: Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54: 3111-3114, 1994.
26. Karlbom A, James C, Boethius J, Cavenee W, Collins V, Nordenskjold M and Lasson C: Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92: 169-174, 1993.
27. Fults D, Brockmeyer D, Tullous M, Pedone C and Cawthon R: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674-679, 1992.
28. Wang S, Puc J, Li J, Bruce J, Cairns P, Sidransky D and Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186, 1997.
29. Rasheed B, McLendon R, Friedman H, Friedman A, Fuchs H, Bigner D and Bigner S: Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246, 1995.
30. Steck P, Ligon A, Cheong P, Yung W and Pershouse M: Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 12: 255-261, 1995.
31. Liaw D, Marsh D, Li J, Dahia P, Wang S, Zheng Z, Bose S, Call K, Tsou H, Peacock M, Eng C and Parsons R: Germline mutations of the PTEN gene in Cowden disease, and inherited breast-thyroid cancer syndrome. Nat Genet 16: 64-67, 1997.
32. Teng D, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen K, Vinson V, Gumpper K, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford L, Lee J, Mills G, Pershouse M, Pollack R, Tornos C, Troncoso P, Yung W, Fujii G, Berson A, Bookstein R, Bolen R, Tavtigian S and Steck P: MMACI/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57: 5221-5225, 1997.
33. Tashiro H, Blazes M, Wu R, Cho K, Bose S, Wang S, Li J, Parsons R and Ellenson L: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997.
34. Myers M, Stolarov J, Eng C, Li J, Wang S, Wigler M, Parsons R and Tonks N: P-TEN, the tumor suppressor from chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057, 1997.
35. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada K: Inhibition of cell migration, spreading and focal adhesions by tumor suppressor gene PTEN. Science 280: 1614-1617, 1998.
36. Ranganathan R and Ross E: PDZ domain proteins: scaffolds for signaling complexes. Curr Biol 7: R770-R773, 1997.
37. Wang S, Parsons R and Ittmann M: Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res 4: 811-815, 1998.
38. Cairns P, Tokino K, Eby Y and Sidransky D: Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1424, 1994.
39. Ittmann M, Wieczorek R, Heller P, Dave A, Provet J and Krolewski J: Alterations in the p53 and MDM-2 genes are infrequent in clinically localized Stage B prostate adenocarcinomas. Am J Pathol 145: 287-293, 1994.
40. Whang Y, Wu X, Suzuki H, Reiter R, Tran C, Vessella R, Said J, Issacs W and Sawyers C: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246-5250, 1998.
41. Nihei N, Ichikawa T, Kawana Y, Kuramochi H, Kugo H, Oshimura M, Killary A, Rinker-Schaeffer C, Barrett J, Issacs J and Shimazaki J: Localization of a metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer 14: 112-119, 1995.
42. Furnari F, Lin H, Huang H and Cavanee W: Growth suppression of glioma cells by PTEN requires a functional phosphatase domain. Proc Natl Acad Sci USA 94: 12479-12484, 1997.
43. Cheney J, Johnson D, Vaillancourt M, Avanzini J, Morimoto A, Demers G, Wills K, Shabram P, Bolen J, Tavtigian S and Bookstein R: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58: 2331-2334, 1998.
44. Molenhauer J, Wiemann S, Scheurlan W, Korn B, Hayashi Y, Wilgenbus K, von Diemling A and Poustka A: DBMT1, a new member of the SRCR superfamily. on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17: 32-39, 1997.
45. Schreiber-Agus N, Meng Y, Hoang T, Hou H, Chen K, Greenberg R, Cardon-Cardo C, Lee H and DePinho R: Role of the Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393: 483-487, 1998.
46. Eagle L, Yin X, Brothman A, Williams B, Atkin N and Prochownik E: Mutation of the MXI1 gene in prostate cancer. Nat Genet 9: 249-255, 1995.
47. Kawamata N, Park D, Wilczynski S, Yokata J and Koeffler H: Point mutations of the Mxi1 gene are rare in prostate cancers. Prostate 29: 191-193, 1996.
48. Kuczyk M, Serth J, Schwede J, Hermann R, Machtens S, Grunewald V, Hofner K and Jonas U: The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. Oncol Rep 5: 213-216, 1998.
49. Sanchez Y, Lovell M, Marin M, Wong P, Wolf-Ledbetter M, McDonnell T and Killary A: Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-q11. Proc Natl Acad Sci USA 93: 2551-2556, 1996.
50. Murakami Y, Albertsen H, Brothman A, Leach R and White R: Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10. Cancer Res 56: 2157-2160, 1996.
51. Chen R: Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1. Cytogenet Cell Genet 62: 183-184, 1993.